PATHOLOGY

$53,407P01FY2008CANIH

Children'S Hospital Of Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 38869684 Paper 38313265 Paper 38200233 Paper 36526235 Paper 34270348 Paper 33739795 Paper 33489468 Paper 32414950 Paper 31068371 Paper 30093449 Paper 29665011 Paper 29603591 Paper 29464082 Paper 29350464 Paper 29017050 Paper 28881723 Paper 28687621 Paper 28559462 Paper 27756784 Paper 27701038 Paper 27530131 Paper 27438153 Paper 27092812 Paper 26884555 Paper 26597947 Paper 26506090 Paper 26254811 Paper 26153194 Paper 26035700 Paper 26029667 Paper 25972604 Paper 25695691 Paper 25648303 Paper 25639769 Paper 25637275 Paper 25602966 Paper 25175806 Paper 25164011 Paper 25145966 Paper 25127139 Paper 25117708 Paper 24889528 Paper 24801042 Paper 24755475 Paper 24599217 Paper 24502925 Paper 24441040 Paper 24336570 Paper 24097859 Paper 24086065 Paper 24040509 Paper 23982484 Paper 23913938 Paper 23901000 Paper 23813912 Paper 23719242 Paper 23658294 Paper 23633489 Paper 23536557 Paper 23482742 Paper 23430699 Paper 23378384 Paper 23209029 Paper 23085857 Paper 22744966 Paper 22700000 Paper 22678283 Paper 22589483 Paper 22389450 Paper 22382618 Paper 22218692 Paper 22125077 Paper 21971567 Paper 21958944 Paper 21933888 Paper 21792658 Paper 21671363 Paper 21497989 Paper 21421857 Paper 21391977 Paper 21340605 Paper 21159612 Paper 21159604 Paper 20935224 Paper 20924375 Paper 20921469 Paper 20871609 Paper 20830775 Paper 20535652 Paper 20424613 Paper 20335016 Paper 20101214 Paper 20009571 Paper 19737959 Paper 19621427 Paper 19411762 Paper 19171716 Paper 19171714 Paper 19171709 Paper 19118018

Abstract

Core B, Pathology, will provide histologic, immunohistochemical, immunofluorescence, and ultrastructural analyses of animal and human specimens for each project. 1. Morphologic analyses on interaction of neuroblastoma cells and stroma cells in tumor progression, invasion, metastasis, and bone destruction using animal models and human samples (Project 1). 2. Histologic and immunohistochemical analyses of immune-mediated "tumor cell killing" in neuroblastomas by using animal models and human tissues (Project 2). 3. Histologic and immunohistochemical analyses of tumors and normal organs of mice treated with retinoids and modifiers (Project 3). 4. Histologic analyses of neuroblastomas to confirm diagnosis and risk classification, as required by clinical study (Project 4).

View original record on NIH RePORTER →